Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Share-based Compensation: 2020-2025

Historic Share-based Compensation for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $7.5 million.

  • Agilon Health's Share-based Compensation fell 4344.97% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.3 million, marking a year-over-year decrease of 1373.23%. This contributed to the annual value of $50.7 million for FY2024, which is 2710.7% down from last year.
  • Agilon Health's Share-based Compensation amounted to $7.5 million in Q3 2025, which was down 4344.97% from $15.4 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Share-based Compensation ranged from a high of $274.5 million in Q2 2021 and a low of $1.5 million during Q1 2021
  • Moreover, its 5-year median value for Share-based Compensation was $13.3 million (2024), whereas its average is $25.3 million.
  • As far as peak fluctuations go, Agilon Health's Share-based Compensation skyrocketed by 1220605.11% in 2021, and later plummeted by 9761.32% in 2022.
  • Quarter analysis of 5 years shows Agilon Health's Share-based Compensation stood at $4.4 million in 2021, then skyrocketed by 125.44% to $10.0 million in 2022, then skyrocketed by 55.91% to $15.5 million in 2023, then tumbled by 85.29% to $2.3 million in 2024, then skyrocketed by 228.57% to $7.5 million in 2025.
  • Its Share-based Compensation stands at $7.5 million for Q3 2025, versus $15.4 million for Q2 2025 and $16.7 million for Q1 2025.